Incremental cost-effectiveness evaluation of vaccinating girls against cervical cancer pre- and post-sexual debut in Belgium. [electronic resource]
Producer: 20140421Description: 3962-71 p. digitalISSN:- 1873-2518
- Adjuvants, Immunologic -- economics
- Adult
- Age Factors
- Aged
- Belgium -- epidemiology
- Child
- Cohort Studies
- Cost-Benefit Analysis
- Cross Protection
- Female
- Human papillomavirus 16 -- pathogenicity
- Human papillomavirus 18 -- pathogenicity
- Humans
- Markov Chains
- Middle Aged
- Models, Theoretical
- Papillomavirus Infections -- economics
- Papillomavirus Vaccines -- economics
- Quality-Adjusted Life Years
- Uterine Cervical Neoplasms -- economics
- Vaccination -- economics
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.